Home / Research Library / The Art of Nanoimmunobiotechnomedicine in Depressi...
🧬 Medicine & Biology PubMed

The Art of Nanoimmunobiotechnomedicine in Depression Management.

📅 November 1, 2025 👤 Anurogo Dito, Ratnasari Ririn Tri, Irmania Novi et al. 📖 Advanced pharmaceutical bulletin

🤖 Plain-English Summary

To explore the role of nanoimmunobiotechnomedicine in depression management, emphasizing how nanotechnology and immunobiology offer innovative approaches to understanding and treating depression. The integration of nanotechnology and immunobiology enhances bioavailability and specificity in targeting depressive disorders at the molecular level.

🔑 Key Findings

  • We investigated the molecular mechanisms underlying depression and integrated multi-omics approaches such as genomics, epigenomics, and bioinformatics to advance therapeutic strategies.
  • An interdisciplinary approach was applied, synthesizing data from epigenetics, nutrigenomics, and advanced bioinformatics.
  • Additionally, molecular and cellular neuroscience techniques were utilized alongside pharmacogenomics to deepen the understanding of depression.

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via PubMed.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Nov 01, 2025
Journal Advanced pharmaceutical bulletin
Authors Anurogo Dito, Ratnasari Ririn Tri, Irmania Novi, Maulana Muhammad Sobri, Audah Kholis Abdurachim
DOI 10.34172/apb.025.42757
Source PubMed

More 🧬 Medicine & Biology Research